CSIMarket
 


Cvs Health Corporation  (CVS)
Other Ticker:  
 
 

CVS's Capital Expenditures Growth by Quarter and Year

Cvs Health's Capital Expenditures results by quarter and year




CVS Capital Expenditures (in millions $) FY 2024 FY 2023 FY 2022 FY 2021
IV Quarter December - 911.00 688.00 597.00
III Quarter September - 545.00 580.00 608.00
II Quarter June - 591.00 408.00 486.00
I Quarter March 705.00 984.00 1,051.00 829.00
FY   705.00 3,031.00 2,727.00 2,520.00



CVS Capital Expenditures first quarter 2024 Y/Y Growth Comment
Cvs Health Corporation reported fall in Capital Expenditures in the first quarter 2024 by -28.35% to $ 705.00 millions, from the same quarter in 2023.
The drop in the first quarter 2024 Cvs Health Corporation's Capital Expenditures compares unfavorably to the Company's average Capital Expenditures decrease of -2.73%.

Looking into first quarter 2024 results within Pharmacy Services & Retail Drugstore industry 3 other companies have achieved higher Capital Expenditures growth. While Cvs Health Corporation' s Capital Expenditures drop of -28.35% ranks overall at the positon no. 1849 in the first quarter 2024.




CVS Capital Expenditures ( Y/Y Growth %) 2024
2023 2022 2021
IV Quarter December - 32.41 % 15.24 % -16.27 %
III Quarter September - -6.03 % -4.61 % 13.86 %
II Quarter June - 44.85 % -16.05 % 8.48 %
I Quarter March -28.35 % -6.37 % 26.78 % 11.73 %
FY   - 11.15 % 8.21 % 3.41 %

Financial Statements
Cvs Health's first quarter 2024 Capital Expenditures $ 705.00 millions CVS's Income Statement
Cvs Health's first quarter 2023 Capital Expenditures $ 984.00 millions Quarterly CVS's Income Statement
New: More CVS's historic Capital Expenditures Growth >>


CVS Capital Expenditures (Quarter on Quarter Growth %)

2024
2023 2022 2021
IV Quarter December - 67.16 % 18.62 % -1.81 %
III Quarter September - -7.78 % 42.16 % 25.1 %
II Quarter June - -39.94 % -61.18 % -41.38 %
I Quarter March -22.61 % 43.02 % 76.05 % 16.27 %
FY (Year on Year)   - 11.15 % 8.21 % 3.41 %




Capital Expenditures first quarter 2024 Y/Y Growth Company Ranking
Within: No.
Pharmacy Services & Retail Drugstore Industry #4
Retail Sector #87
Overall #1849

Capital Expenditures Y/Y Growth Statistics
High Average Low
48.55 % -2.73 % -100 %
(Mar 31 2019)   (Dec 31 2011)
Capital Expenditures first quarter 2024 Y/Y Growth Company Ranking
Within: No.
Pharmacy Services & Retail Drugstore Industry #4
Retail Sector #87
Overall #1849
Capital Expenditures Y/Y Growth Statistics
High Average Low
48.55 % -2.73 % -100 %
(Mar 31 2019)   (Dec 31 2011)

Capital Expenditures by Quarter for the Fiscal Years 2021, 2022, 2023, 2024

Cvs Health's Q/Q Capital Expenditures Growth


Capital Expenditures Q/Q Growth Statistics
High Average Low
133.98 % 9.9 % -100 %
(June 30. 2009)  


CVS's I. Quarter Q/Q Capital Expenditures Comment
In the I. Quarter 2024 Cvs Health Corporation realized fall in Capital Expenditures sequentially by -22.61% to $ 705.00 millions, from $ 911.00 millions released a quarter before.

Even periodic circumstance have not recover the I. Quarter for the Cvs Health Corporation, Carmen Navarro, market insider located in Valencia said, she detected additional headwinds down the road for Cvs Health.

Within Pharmacy Services & Retail Drugstore industry 3 other companies have achieved higher Capital Expenditures quarter on quarter growth. While Cvs Health's Capital Expenditures growth quarter on quarter, overall rank is 1470.


Capital Expenditures Q/Q Growth Company Ranking
Within: No.
Pharmacy Services & Retail Drugstore Industry #4
Retail Sector #75
Overall #1470
Capital Expenditures Q/Q Growth Company Ranking
Within: No.
Pharmacy Services & Retail Drugstore Industry #4
Retail Sector #75
Overall #1470
Capital Expenditures Q/Q Growth Statistics
High Average Low
133.98 % 9.9 % -100 %
(June 30. 2009)  


CVS's I. Quarter Q/Q Capital Expenditures Comment
In the I. Quarter 2024 Cvs Health Corporation disclosed fall in Capital Expenditures from the fourth quarter by -22.61% to $ 705.00 millions, from $ 911.00 millions achived a quarter before.

Although seasonal factors normally energize I. Quarter 2024 Capital Expenditures, it clearly could not be substantial to rescue Pharmacy Services & Retail Drugstore's company I. Quarter outcome, Carmen Navarro, market insider located in Valencia pointed out and mentioned that average sequential Capital Expenditures growth is at 9.9% for Cvs Health.

Within Pharmacy Services & Retail Drugstore industry 3 other companies have achieved higher Capital Expenditures quarter on quarter growth. While Cvs Health's Capital Expenditures growth quarter on quarter, overall rank is 1470.


Cvs Health's 12 Months Capital Expenditures Growth Year on Year


Capital Expenditures TTM Growth

12 Months Ending
(Mar 31 2024)
12 Months Ending
(Dec 31 2023)
12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
Cumulative Capital Expenditures 12 Months Ending $ 2,752.00 $ 3,031.00 $ 2,808.00 $ 2,843.00 $ 2,660.00
Y / Y Capital Expenditures Growth (TTM) 3.46 % 11.15 % 6.53 % 6.72 % -2.99 %
Year on Year Capital Expenditures Growth Overall Ranking # 484 # 122 # 582 # 384 # 388
Seqeuential Capital Expenditures Change (TTM) -9.2 % 7.94 % -1.23 % 6.88 % -2.46 %
Seq. Capital Expenditures Growth (TTM) Overall Ranking # 1112 # 132 # 1417 # 436 # 865




Cumulative Capital Expenditures growth Comment
With the quarterly Capital Expenditures reported in the Mar 31 2024 period, Cvs Health's cumulative twelve months Capital Expenditures were $ 2,752 millions, company would post below average annual Capital Expenditures growth of -2.46% year on year, if the fiscal year would end at Mar 31 2024.
A slow-down in the Cvs Health's Capital Expenditures growth from the 911% growth in Dec 31 2023.

Within the Retail sector 21 other companies have achieved higher trailing twelve month Capital Expenditures growth. While Capital Expenditures growth total ranking has deteriorated compare to previous quarter from 122 to 484.

Capital Expenditures TTM Q/Q Growth Statistics
High Average Low
359.52 %
10.04 %
-38.15 %
 

Capital Expenditures TTM Y/Y Growth Company Ranking
Within: No.
Pharmacy Services & Retail Drugstore Industry # 6
Retail Sector # 22
Overall # 484

Capital Expenditures TTM Y/Y Growth Statistics
High Average Low
359.52 %
10.04 %
-38.15 %
 


Capital Expenditures TTM Q/Q Growth Company Ranking
Within: No.
Industry # 6
Sector # 70
S&P 500 # 1112
Cumulative Capital Expenditures growth Comment
With the quarterly Capital Expenditures reported in the Mar 31 2024 period, Cvs Health's cumulative twelve months Capital Expenditures were $ 2,752 millions, company would post below average annual Capital Expenditures growth of -38.15% year on year, if the fiscal year would end at Mar 31 2024.
A slow-down in the Cvs Health's Capital Expenditures growth from the 911% growth in Dec 31 2023.

Within the Retail sector 21 other companies have achieved higher trailing twelve month Capital Expenditures growth. While Capital Expenditures growth total ranking has deteriorated compare to previous quarter from 122 to 484.

Capital Expenditures TTM Q/Q Growth Statistics
High Average Low
359.52 %
10.04 %
-38.15 %
 


Capital Expenditures TTM Y/Y Growth Company Ranking
Within: No.
Pharmacy Services & Retail Drugstore Industry # 6
Retail Sector # 22
Overall # 484

Capital Expenditures TTM Y/Y Growth Statistics
High Average Low
359.52 %
10.04 %
-38.15 %
 


Capital Expenditures TTM Q/Q Growth Company Ranking
Within: No.
Industry # 6
Sector # 70
S&P 500 # 1112




Other Capital Expenditures Growth
Pharmacy Services & Retail Drugstore Industry Capital Expenditures Growth Trends and Statistics
Retail Sector Capital Expenditures Growth Statistics
Capital Expenditures Growth Trends for overall market
CVS's Capital Expenditures Growth Ratio versus Pharmacy Services & Retail Drugstore Industry, Retail Sector and total Market
Highest Ranking Capital Expenditures Growth
Lowest Ranking Capital Expenditures Growth
Capital Expenditures Growth for CVS's Competitors
Capital Expenditures Growth for Cvs Health's Suppliers
Capital Expenditures Growth for CVS's Customers

You may also want to know
CVS's Annual Growth Rates CVS's Profitability Ratios CVS's Asset Turnover Ratio CVS's Dividend Growth
CVS's Roe CVS's Valuation Ratios CVS's Financial Strength Ratios CVS's Dividend Payout Ratio
CVS's Roa CVS's Inventory Turnover Ratio CVS's Growth Rates CVS's Dividend Comparisons



Companies with similar Capital Expenditures fall for the quarter ending Mar 31 2024 within Retail SectorY/Y Change %Capital Expenditures for the quarter ending Mar 31 2024
Autonation Inc -1.68%$ -1.679 millions
Haverty Furniture Companies Inc-3.85%$ -3.847 millions
Cdw Corp-6.94%$ -6.940 millions
Rush Enterprises Inc -12.50%$ -12.505 millions
Charles and Colvard Ltd -16.30%$ -16.302 millions
Petiq Inc -18.85%$ -18.848 millions
Floor and Decor Holdings Inc -19.88%$ -19.878 millions
Rave Restaurant Group Inc -21.05%$ -21.053 millions
Cvs Health Corporation-28.35%$ -28.354 millions
Insight Enterprises Inc -28.82%$ -28.816 millions
Grove Collaborative Holdings Inc -33.93%$ -33.929 millions
Petmed Express Inc -35.21%$ -35.215 millions
Lazydays Holdings Inc -37.11%$ -37.105 millions
Ezcorp Inc -42.52%$ -42.525 millions
Carvana Co -43.75%$ -43.750 millions
A k a Brands Holding Corp -59.84%$ -59.840 millions
Wayfair inc -61.76%$ -61.765 millions
Therealreal Inc -66.58%$ -66.577 millions
Evgo Inc -67.71%$ -67.705 millions
Plby Group Inc -67.91%$ -67.909 millions
Thredup Inc -71.47%$ -71.474 millions
Eplus Inc -78.52%$ -78.516 millions
The Honest Company Inc -83.93%$ -83.932 millions
Brilliant Earth Group Inc -87.27%$ -87.268 millions
Growgeneration Corp -89.79%$ -89.787 millions
Bark Inc -90.00%$ -90.000 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com